Microprofit Biotech Shines at MEDICA 2024

From November 11th to 14th, 2024, the world's leading medical trade fair, MEDICA 2024, was held at the Düsseldorf Exhibition Center in Germany. As the most influential international event in the medical industry, MEDICA 2024 attracted over 5,500 exhibitors from more than 70 countries and regions. As an innovative leader in China’s in-vitro diagnostics (IVD) sector, Microprofit Biotech proudly showcased its cutting-edge products, including rapid tests for respiratory infections, monkeypox, and tropical diseases, the FIA quantitative POCT platform, high-quality biological reagent raw materials, and intelligent diagnostic equipment — joining global industry peers in presenting the latest advancements in medical and healthcare technology.

As a seasoned exhibitor in the IVD field, the Microprofit team warmly welcomed representatives from manufacturers, distributors, doctors, and researchers worldwide. Among the highlights was the company’s self-developed multi-in-1 combo test kit for respiratory infections, which provided an innovative solution for clinical pathogen detection. Its high efficiency and accuracy attracted widespread attention and earned high praise from attendees. This groundbreaking product not only offers doctors a more comprehensive diagnostic tool but also provides patients with more convenient and reliable testing options.

Microprofit’s fluorecare® FIA quantitative POCT platform and newly developed testing instruments also garnered significant interest. Their diverse testing options, user-friendly processes, and highly accurate results impressed many visitors. In addition, Microprofit presented 24 types of biological reagent raw materials, offering high-quality production support to industry peers and attracting attention from numerous manufacturers.

With over 15 years of experience in the IVD field, Microprofit has consistently upheld a commitment to independent innovation, continuously breaking through technical barriers. The company holds more than 40 invention patents and over 150 CE certifications. Its strong R&D capabilities and exceptional product quality have enabled Microprofit to establish partnerships in over 100 countries and regions worldwide.

Microprofit's successful participation in MEDICA 2024 not only strengthened its global brand presence and showcased its product portfolio but also created a platform for expanding international collaboration. Moving forward, Microprofit will continue to partner with industry leaders, driving innovation in China's medical and healthcare sector and delivering more advanced solutions to global healthcare.

The exhibition is in full swing — Microprofit looks forward to welcoming you at Hall 3, Stand 3K72-C!